AVEO Oncology
AVEO
#7558
Rank
S$0.66 B
Marketcap
S$19.17
Share price
0.00%
Change (1 day)
169.28%
Change (1 year)

AVEO Oncology (AVEO) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : S$92.5 Million

According to AVEO Oncology 's latest financial reports the company's total liabilities are S$92.5 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AVEO Oncology - Total liabilities on balance sheet (from 2008 to 2022)

Total liabilities by year

Year Total liabilities Change
2021-12-31S$80.39 M92.21%
2020-12-31S$41.82 M-13.22%
2019-12-31S$48.2 M-36.04%
2018-12-31S$75.35 M-38.06%
2017-12-31S$0.12 B187.8%
2016-12-31S$42.27 M28.18%
2015-12-31S$32.97 M-50.14%
2014-12-31S$66.14 M-31.68%
2013-12-31S$96.8 M-10.58%
2012-12-31S$0.10 B16.91%
2011-12-31S$92.6 M-9.31%
2010-12-31S$0.10 B1.07%
2009-12-31S$0.10 B-58.14%
2008-12-31S$0.24 B0.97%
2007-12-31S$0.23 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eli Lilly
LLY
S$109.10 B 117,844.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$106.46 B 114,993.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$13.84 B 14,862.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$12.07 B 12,948.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$84.81 B 91,591.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
S$28.97 M-68.68%๐Ÿ‡บ๐Ÿ‡ธ USA